Zimmer L, Livingstone E, Hassel JC, Fluck M, et al. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in
patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a
randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 2020;395:1558-1568.
PMID: 32416781